Treatment Options and Survival of Metastatic Prostate Cancer Patients

Abstract

In this proposal, we will utilize a prostate cancer cohort from the VA hospitals to explore the survival benefit among men diagnosed with metastatic prostate cancer who receive definitive treatment (alone or with adjuvant therapies) compared to men who receive nondefinitive treatment; and we will assess the treatment related side effects that affect quality of life among men diagnosed with metastatic prostate cancer who receive definitive vs. non-definitive treatment. The specific aims are: Aim 1: To examine the survival benefit among men diagnosed with metastatic prostate cancer that receive definitive treatment compared to men that receive non-definitive treatment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2022
Accession Number
AD1190412

Entities

People

  • Bettina F. Drake

Organizations

  • Washington University in St. Louis

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Androgen Receptors
  • Biomedical Research
  • Cancer
  • Cardiovascular Diseases
  • Data Analysis
  • Department Of Defense
  • Diseases
  • Disparities
  • Electronic Mail
  • Health
  • Health Services
  • Maryland
  • Medical Personnel
  • Neoplasms
  • Professional Development
  • Prostate
  • Prostate Cancer
  • Quality Of Life
  • Side Effects
  • Standards

Fields of Study

  • Medicine

Readers

  • Oncology and Biomarker-Based Cancer Detection.
  • Psychological Intervention/Treatment for Stress, Anxiety, PTSD, and Related Emotional and Cognitive Health Symptoms.